The role of dexmedetomidine as an adjuvant for high-thoracic erector spinae plane block for analgesia in shoulder arthroscopy; a randomized controlled study

Abstract Background Management of postoperative pain after shoulder arthroscopy is an important issue. Dexmedetomidine, as an adjuvant, improves nerve block efficacy and decreases postoperative consumption of opioids. As a result, we designed this study to determine if adding dexmedetomidine to an e...

Full description

Bibliographic Details
Main Authors: Mohamed Ahmed Hamed, Omar Sayed Fargaly, Rana Ahmed Abdelghaffar, Mohammed Ahmed Moussa, Mohammad Fouad Algyar
Format: Article
Language:English
Published: BMC 2023-02-01
Series:BMC Anesthesiology
Subjects:
Online Access:https://doi.org/10.1186/s12871-023-02014-2
_version_ 1827982986296950784
author Mohamed Ahmed Hamed
Omar Sayed Fargaly
Rana Ahmed Abdelghaffar
Mohammed Ahmed Moussa
Mohammad Fouad Algyar
author_facet Mohamed Ahmed Hamed
Omar Sayed Fargaly
Rana Ahmed Abdelghaffar
Mohammed Ahmed Moussa
Mohammad Fouad Algyar
author_sort Mohamed Ahmed Hamed
collection DOAJ
description Abstract Background Management of postoperative pain after shoulder arthroscopy is an important issue. Dexmedetomidine, as an adjuvant, improves nerve block efficacy and decreases postoperative consumption of opioids. As a result, we designed this study to determine if adding dexmedetomidine to an erector spinae plane block (ESPB) that is guided by ultrasound (US) is beneficial for treating immediate postoperative pain following shoulder arthroscopy. Methods This randomized controlled double-blind trial recruited 60 cases 18–65 years old of both sexes, American Society of Anesthesiologists (ASA) physical status I-II, scheduled for elective shoulder arthroscopy. Random allocation of 60 cases was done equally into two groups according to the solution injected in US-guided ESPB at T2 before general anesthetic induction. Group (ESPB): 20 ml 0.25% bupivacaine. Group (ESPB + DEX): 19 ml bupivacaine 0.25% + 1 mL dexmedetomidine 0.5 µg/kg. The primary outcome was The total rescue morphine consumption in the first 24 postoperative hours. Results The mean intraoperative fentanyl consumption was significantly lower in the group (ESPB + DEX) compared to the group (ESPB) (82.86 ± 13.57 versus 100.74 ± 35.07, respectively, P = 0.015). The median (IQR) time of the 1st rescue analgesic request was significantly delayed in the group (ESPB + DEX) compared to group (ESPB) [18.5 (18.25–18.75) versus 12 (12–15.75), P = 0.044]. The number of cases that required morphine was significantly lower in the group (ESPB + DEX) than in the group (ESPB) (P = 0.012). The median (IQR) of total postoperative morphine consumption in 1st 24 h was significantly lower in the group (ESPB + DEX) compared to the group (ESPB) [0 (0–0) versus 0 (0–3), P = 0.021]. Conclusion The dexmedetomidine as an adjuvant to bupivacaine in ESPB produced adequate analgesia by reducing the intraoperative and postoperative opioid requirements in shoulder arthroscopy. Trial Registration This study is registered on ClinicalTrials.gov (NCT05165836; principal investigator: Mohammad Fouad Algyar; registration date: 21/12/ 2021).
first_indexed 2024-04-09T22:40:40Z
format Article
id doaj.art-976ced2e02644561b92e37c1180cc72b
institution Directory Open Access Journal
issn 1471-2253
language English
last_indexed 2024-04-09T22:40:40Z
publishDate 2023-02-01
publisher BMC
record_format Article
series BMC Anesthesiology
spelling doaj.art-976ced2e02644561b92e37c1180cc72b2023-03-22T12:12:33ZengBMCBMC Anesthesiology1471-22532023-02-012311710.1186/s12871-023-02014-2The role of dexmedetomidine as an adjuvant for high-thoracic erector spinae plane block for analgesia in shoulder arthroscopy; a randomized controlled studyMohamed Ahmed Hamed0Omar Sayed Fargaly1Rana Ahmed Abdelghaffar2Mohammed Ahmed Moussa3Mohammad Fouad Algyar4Department of Anesthesiology, Faculty of Medicine, Fayoum UniversityDepartment of Anesthesiology, Faculty of Medicine, Fayoum UniversityDepartment of Anesthesiology, Faculty of Medicine, Fayoum UniversityDepartment of Orthopedics, Faculty of Medicine, Fayoum UniversityDepartment of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Kafrelsheikh UniversityAbstract Background Management of postoperative pain after shoulder arthroscopy is an important issue. Dexmedetomidine, as an adjuvant, improves nerve block efficacy and decreases postoperative consumption of opioids. As a result, we designed this study to determine if adding dexmedetomidine to an erector spinae plane block (ESPB) that is guided by ultrasound (US) is beneficial for treating immediate postoperative pain following shoulder arthroscopy. Methods This randomized controlled double-blind trial recruited 60 cases 18–65 years old of both sexes, American Society of Anesthesiologists (ASA) physical status I-II, scheduled for elective shoulder arthroscopy. Random allocation of 60 cases was done equally into two groups according to the solution injected in US-guided ESPB at T2 before general anesthetic induction. Group (ESPB): 20 ml 0.25% bupivacaine. Group (ESPB + DEX): 19 ml bupivacaine 0.25% + 1 mL dexmedetomidine 0.5 µg/kg. The primary outcome was The total rescue morphine consumption in the first 24 postoperative hours. Results The mean intraoperative fentanyl consumption was significantly lower in the group (ESPB + DEX) compared to the group (ESPB) (82.86 ± 13.57 versus 100.74 ± 35.07, respectively, P = 0.015). The median (IQR) time of the 1st rescue analgesic request was significantly delayed in the group (ESPB + DEX) compared to group (ESPB) [18.5 (18.25–18.75) versus 12 (12–15.75), P = 0.044]. The number of cases that required morphine was significantly lower in the group (ESPB + DEX) than in the group (ESPB) (P = 0.012). The median (IQR) of total postoperative morphine consumption in 1st 24 h was significantly lower in the group (ESPB + DEX) compared to the group (ESPB) [0 (0–0) versus 0 (0–3), P = 0.021]. Conclusion The dexmedetomidine as an adjuvant to bupivacaine in ESPB produced adequate analgesia by reducing the intraoperative and postoperative opioid requirements in shoulder arthroscopy. Trial Registration This study is registered on ClinicalTrials.gov (NCT05165836; principal investigator: Mohammad Fouad Algyar; registration date: 21/12/ 2021).https://doi.org/10.1186/s12871-023-02014-2DexmedetomidineErector spinae plane blockShoulder arthroscopy
spellingShingle Mohamed Ahmed Hamed
Omar Sayed Fargaly
Rana Ahmed Abdelghaffar
Mohammed Ahmed Moussa
Mohammad Fouad Algyar
The role of dexmedetomidine as an adjuvant for high-thoracic erector spinae plane block for analgesia in shoulder arthroscopy; a randomized controlled study
BMC Anesthesiology
Dexmedetomidine
Erector spinae plane block
Shoulder arthroscopy
title The role of dexmedetomidine as an adjuvant for high-thoracic erector spinae plane block for analgesia in shoulder arthroscopy; a randomized controlled study
title_full The role of dexmedetomidine as an adjuvant for high-thoracic erector spinae plane block for analgesia in shoulder arthroscopy; a randomized controlled study
title_fullStr The role of dexmedetomidine as an adjuvant for high-thoracic erector spinae plane block for analgesia in shoulder arthroscopy; a randomized controlled study
title_full_unstemmed The role of dexmedetomidine as an adjuvant for high-thoracic erector spinae plane block for analgesia in shoulder arthroscopy; a randomized controlled study
title_short The role of dexmedetomidine as an adjuvant for high-thoracic erector spinae plane block for analgesia in shoulder arthroscopy; a randomized controlled study
title_sort role of dexmedetomidine as an adjuvant for high thoracic erector spinae plane block for analgesia in shoulder arthroscopy a randomized controlled study
topic Dexmedetomidine
Erector spinae plane block
Shoulder arthroscopy
url https://doi.org/10.1186/s12871-023-02014-2
work_keys_str_mv AT mohamedahmedhamed theroleofdexmedetomidineasanadjuvantforhighthoracicerectorspinaeplaneblockforanalgesiainshoulderarthroscopyarandomizedcontrolledstudy
AT omarsayedfargaly theroleofdexmedetomidineasanadjuvantforhighthoracicerectorspinaeplaneblockforanalgesiainshoulderarthroscopyarandomizedcontrolledstudy
AT ranaahmedabdelghaffar theroleofdexmedetomidineasanadjuvantforhighthoracicerectorspinaeplaneblockforanalgesiainshoulderarthroscopyarandomizedcontrolledstudy
AT mohammedahmedmoussa theroleofdexmedetomidineasanadjuvantforhighthoracicerectorspinaeplaneblockforanalgesiainshoulderarthroscopyarandomizedcontrolledstudy
AT mohammadfouadalgyar theroleofdexmedetomidineasanadjuvantforhighthoracicerectorspinaeplaneblockforanalgesiainshoulderarthroscopyarandomizedcontrolledstudy
AT mohamedahmedhamed roleofdexmedetomidineasanadjuvantforhighthoracicerectorspinaeplaneblockforanalgesiainshoulderarthroscopyarandomizedcontrolledstudy
AT omarsayedfargaly roleofdexmedetomidineasanadjuvantforhighthoracicerectorspinaeplaneblockforanalgesiainshoulderarthroscopyarandomizedcontrolledstudy
AT ranaahmedabdelghaffar roleofdexmedetomidineasanadjuvantforhighthoracicerectorspinaeplaneblockforanalgesiainshoulderarthroscopyarandomizedcontrolledstudy
AT mohammedahmedmoussa roleofdexmedetomidineasanadjuvantforhighthoracicerectorspinaeplaneblockforanalgesiainshoulderarthroscopyarandomizedcontrolledstudy
AT mohammadfouadalgyar roleofdexmedetomidineasanadjuvantforhighthoracicerectorspinaeplaneblockforanalgesiainshoulderarthroscopyarandomizedcontrolledstudy